Flossbach Von Storch’s BioNTech BNTX Stock Holding History

Flossbach Von Storch’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$327M	Sell	3,680,315 -515,733	-12%	-$53M	1.53%	22
2025 Q4	$399M	Sell	4,196,048 -33,985	-0.8%	-$3.42M	1.58%	21
2025 Q3	$417M	Sell	4,230,033 -65	-0%	-$6.95K	1.64%	24
2025 Q2	$450M	Sell	4,230,098 -29,533	-0.7%	-$2.98M	1.84%	21
2025 Q1	$388M	Sell	4,259,631 -147,212	-3%	-$16.5M	1.68%	21
2024 Q4	$502M	Buy	4,406,843 +47,236	+1%	+$5.39M	2%	20
2024 Q3	$518M	Sell	4,359,607 -19,876	-0.5%	-$1.83M	2.03%	21
2024 Q2	$352M	Buy	4,379,483 +910,497	+26%	+$83.2M	1.48%	20
2024 Q1	$320M	Sell	3,468,986 -79,674	-2%	-$7.64M	1.39%	19
2023 Q4	$375M	Buy	3,548,660 +35,445	+1%	+$3.57M	1.71%	19
2023 Q3	$382M	Buy	3,513,215 +71,468	+2%	+$7.9M	1.68%	21
2023 Q2	$371M	Buy	3,441,747 +9,413	+0.3%	+$1.06M	1.5%	21
2023 Q1	$428M	Buy	3,432,334 +149,611	+5%	+$20.5M	1.8%	21
2022 Q4	$493M	Sell	3,282,723 -81,841	-2%	-$12.6M	1.88%	26
2022 Q3	$454M	Buy	3,364,564 +299,414	+10%	+$45.8M	1.67%	29
2022 Q2	$457M	Buy	3,065,150 +1,145,061	+60%	+$175M	1.53%	30
2022 Q1	$327M	Buy	+1,920,089	New	+$323M	0.91%	35

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GSK plc London $599M AUM

Flossbach Von Storch's BNTX Position: Q1 2026 in Review

Flossbach Von Storch reduced its BioNTech (BNTX) stake by 12% in Q1 2026, selling an estimated $53M and leaving 3,680,315 shares worth $327M. The position accounts for 1.53% of the portfolio, ranked #22.

Flossbach Von Storch first reported a position in BNTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $518M in Q3 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Flossbach Von Storch held 3,680,315 shares of BioNTech worth $327M as of Q1 2026.
Flossbach Von Storch sold 515,733 BioNTech shares in Q1 2026, an estimated $53M.
BioNTech made up 1.53% of Flossbach Von Storch's portfolio in Q1 2026, its #22 holding.
Flossbach Von Storch first reported a position in BioNTech in Q1 2022 and has held it in 17 quarters since.
Flossbach Von Storch's BioNTech position peaked at $518M in Q3 2024.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Flossbach Von Storch's 13F filing for Q1 2026, filed 29 Apr 2026.